In 2015, Barry and Joy Lambert made an unprecedented donation of $33.7 million to the University of Sydney for research into the therapeutic use of medicinal cannabis. This resulted in the Lambert Initiative.
The Lambert initiative is an Australian first in the field of medicinal cannabinoids – both in its breadth and depth of research innovation.
We are targeting a range of conditions including paediatric epilepsy, cancer, chronic pain, obesity, neurological, and mental health disorders.
Our approach involves using medicinal chemistry, cellular and preclinical research, early human testing and clinical trials in patients to identify and develop novel cannabinoid-based therapeutics.
We are also translating research outcomes into practice by providing outreach to the community and to health professionals, and engaging consumer organisations and media to educate the public and transform current policy.
Our aim is to optimise and introduce safe and effective cannabinoid therapeutics into mainstream medicine in Australia and beyond.
Welcome to the Lambert Initiative. Join us in the voyage of discovery.